Our mission is to make exceptional, innovative biopharmaceuticals to improve the lives of patients suffering from serious diseases.
Taking Big Steps
MorphoSys' mission
17/09/2020
MorphoSys and Incyte to Host Investor Event to Discuss the Unmet Need and...
17/09/2020
MorphoSys and I-Mab Announce FDA Clearance of IND Application for MOR210/...
18/08/2020
National Comprehensive Cancer Network(R) Adds Monjuvi(R) (tafasitamab-cxix...
01/08/2020
MorphoSys AG: Ad hoc: FDA Approves Monjuvi(R) (tafasitamab-cxix) in...
30/07/2020
Invitation to MorphoSys' Second Quarter and First Half 2020 Results...
14/07/2020
MorphoSys' Licensee Janssen Announces Approval of Tremfya (Guselkumab...
